Search - tctmd.com

Displaying 121 - 140 of 175

Sort: Relevancy | Date

Presentation EuroPCR 2018

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

Presenter: Panagiotis Xaplanteris

May 23, 2018

Presentation EuroPCR 2018

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

Presenter: Frederik M. Zimmermann

May 23, 2018

News Conference News EuroPCR 2018

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

Yael L. Maxwell

May 22, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Conference News EuroPCR 2018

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

Caitlin E. Cox

May 22, 2018

Presentation EuroPCR 2018

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

Presenter: Rasha Al-Lamee

May 22, 2018

News Conference News EuroPCR 2018

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

Michael O'Riordan

May 22, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

CT Imaging in Ischemic Heart Disease: CTA, CT-FFR, and CT-Perfusion Current Uses and Future Projections

Presenter: Jane Cao

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Understanding Mechanisms of Regulation of Resting and Hyperaemic Blood Flow

Presenter: Rasha Al-Lamee

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Should we be using a dichotomous cut-point? Understanding mismatch between iFR and FFR

Presenter: Allen Jeremias

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Is physiologic lesion assessment mandatory for every PCI in stable angina patients

Presenter: Morton Kern

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Is FFR a Substitute For Sound Clinical Judgment?

Presenter: Jeffrey W. Moses

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

Presenter: Allen Jeremias

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Are all Resting Indices the Same?

Presenter: Johan Svanerud

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Angiography Based FFR- Ready for Clinical Use?

Presenter: Ori Ben-Yehuda

May 06, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Show me the Data: Evidence that Physiologic Lesion Assessment Improves Patient Outcomes (or provides clinical value)

Presenter: Morton J. Kern

May 05, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

ORBITA Trial

Presenter: Paul S. Teirstein

May 05, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

How Do I Assess (and Treat) Tandem Lesions & Diffuse Disease

Presenter: Ajay J. Kirtane

May 05, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

Caitlin E. Cox

April 30, 2018

Advertisement

Five-year Outcomes with PCI Guided by Fractional Flow Reserve in Patients with Stable Coronary Artery Disease (FAME 2)

FFR-guided PCI versus Medical Therapy to Reduce Cardiac Death or Myocardial Infarction

‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

FFR in PCI for Stable CAD: Lasting Benefit Shown by FAME 2, SCAAR Data

ORBITA: A Physiology-stratified Analysis of the Impact of FFR and iFR on Efficacy of Coronary Angioplasty in Stable Coronary Artery Disease

FFR-Guided PCI Reduces Risk of Death/MI Compared With Medical Therapy: Pooled Analysis

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

CT Imaging in Ischemic Heart Disease: CTA, CT-FFR, and CT-Perfusion Current Uses and Future Projections

Understanding Mechanisms of Regulation of Resting and Hyperaemic Blood Flow

Should we be using a dichotomous cut-point? Understanding mismatch between iFR and FFR

Is physiologic lesion assessment mandatory for every PCI in stable angina patients

Is FFR a Substitute For Sound Clinical Judgment?

Combined analysis of DEFINE-FLAIR and iFR Swedeheart: Safety of PCI deferral in stable CAD and ACS

Are all Resting Indices the Same?

Angiography Based FFR- Ready for Clinical Use?

Show me the Data: Evidence that Physiologic Lesion Assessment Improves Patient Outcomes (or provides clinical value)

ORBITA Trial

How Do I Assess (and Treat) Tandem Lesions & Diffuse Disease

TCTMD’s Top 10 Most Popular Stories for April 2018

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content